Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026
Rhea-AI Summary
Bionano Genomics (NASDAQ: BNGO) will report first quarter 2026 financial results and host a conference call and live webcast on Wednesday, May 13, 2026 at 4:30 p.m. ET.
Participants can register via links on the company's investors page; a replay will be archived on Bionano's investor relations website for at least 30 days. Company and investor-relations contacts are provided for follow-up.
Positive
- None.
Negative
- None.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 09 | Earnings call scheduling | Neutral | +0.9% | Set date and time for Q4 and full-year 2025 earnings call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date conference call notices saw a modestly positive price reaction.
Recent Bionano news combined clinical and financial developments. A prior earnings-date announcement on Mar 09, 2026 about reporting Q4 2025 and full-year results led into detailed results and guidance later in March. That scheduling headline was followed by a 0.89% gain over 24 hours. Today’s notice similarly sets expectations for discussing Q1 2026 performance and recent corporate progress on May 13, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 13, 2026, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2026 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Wednesday, May 13th, 2026 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | Registration – Click here |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
Contacts
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Webb Campbell
Gilmartin Group
+1 (415) 520-5817
IR@bionano.com